ArticleISRN oncology2011
Brain metastases from ovarian carcinoma.
Article in ISRN oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.
- Brain metastasis from ovarian cancer: a systematic review.Journal of neuro-oncology · 2014Pooled it
- Brain metastases as a manifestation of late relapse in high-grade serous ovarian cancer: Diagnostic and therapeutic challenges.Radiology case reports · 2026Article
- Article
- Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers.NPJ precision oncology · 2026Article
- Brain metastasis of ovarian cancer >20 years after initial diagnosis: A case report.Oncology letters · 2026Article
- Ovarian Carcinoma Initially-presented as Cerebral Metastasis: Epidemiology, Pathology, and Outcomes.Materia socio-medica · 2025Article
- Article
- Cerebellar metastasis of ovarian cancer: a case report.Journal of medical case reports · 2023Article
- Article
- Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting.Journal of clinical medicine · 2023Article
- Prognosis of patients treated in a single neurosurgical reference centre for brain metastasis caused by dormant disseminated cells.Oncology letters · 2021Article
- Article
- Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours.Clinical and translational radiation oncology · 2020Article
- Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis.Cancers · 2020Review
- Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.Journal of ovarian research · 2020Article
- Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study.Journal of Cancer · 2020Article
- Epithelial Ovarian Carcinoma Associated with Metastases to Central Nervous System: Two Case Reports.Case reports in obstetrics and gynecology · 2018Article
- Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation.Gynecologic oncology reports · 2017Article
- Androgen receptor status predicts development of brain metastases in ovarian cancers.Oncotarget · 2017Article
- Leptomeningeal carcinomatosis and bilateral internal auditory canal metastases from ovarian carcinoma.Radiology case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper will focus on knowledge related to brain metastases from ovarian carcinoma. So far, less than 600 cases were documented in the literature with an incidence among ovarian carcinoma patients ranging from 0.29% to 11.6%. The ovarian carcinoma was usually an advanced-stage epithelial serous carcinoma, and the median interval between diagnosis of ovarian carcinoma and brain metastases was 2 years. Most often, brain metastases, affected the cerebrum, were multiple and part of a disseminated disease. Treatment of brain metastasis has evolved over the years from whole brain radiotherapy (WBRT) only to multimodal therapy including surgical resection or stereotactic radiosurgery followed by WBRT and/or chemotherapy. The median survival after diagnosis of brain metastases was 6 months; nevertheless, a significantly better survival was achieved with multimodal therapy compared to WBRT only. It is suggested that brain imaging studies should be included in the followup of patients after treatment for ovarian carcinoma.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.